BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15800680)

  • 21. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
    Youssef MY; Mohamed MA
    Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FHIT expression in neoplastic, hyperplastic, and normal endometrium.
    Ozkara SK; Corakçi A
    Int J Gynecol Cancer; 2005; 15(6):1081-8. PubMed ID: 16343185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
    Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
    Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
    Lin Z; Cho S; Jeong H; Kim H; Kim I
    J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
    Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ
    Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MMP-26 mRNA and estrogen receptor alpha co-expression in normal and pathological endometrium].
    Pilka R; Kudela M; Eriksson P; Casslén B
    Ceska Gynekol; 2005 Jan; 70(1):56-62. PubMed ID: 15779297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
    Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
    Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Expression Patterns of PTEN in Cyclic, Hyperplastic and Malignant Endometrium: Its Relation with ER, PR and Clinicopathological Parameters.
    Abd El-Maqsoud NM; El-Gelany S
    J Egypt Natl Canc Inst; 2009 Dec; 21(4):323-31. PubMed ID: 21415869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptor and cellular retinol-binding protein-1 immunohistochemical expression in normal, hyperplastic and neoplastic endometrium: Possible diagnostic and therapeutic implications.
    Badary DM; Abou-Taleb H
    Ann Diagn Pathol; 2020 Oct; 48():151569. PubMed ID: 32805516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium.
    Shevra CR; Ghosh A; Kumar M
    J Postgrad Med; 2015; 61(1):15-20. PubMed ID: 25511212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
    Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
    Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of steroid receptors, proliferation markers, apoptosis related molecules, and gelatinases in non-neoplastic and neoplastic endometrium.
    Amalinei C; Cianga C; Balan R; Cianga P; Giusca S; Caruntu ID
    Ann Anat; 2011 Feb; 193(1):43-55. PubMed ID: 21145716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
    Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
    Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression.
    Watanabe J; Yokoyama Y; Futagami M; Mizunuma H; Yoshioka H; Washiya K; Hana K; Endou H; Okayasu I
    Int J Gynecol Cancer; 2014 May; 24(4):659-63. PubMed ID: 24694899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.